Lindsey A Edwards1, Anna K Nowocin2, Nazila V Jafari2, Lucy L Meader2, Kathryn Brown2, Aurélien Sarde2, Carolyn Lam2, Alex Murray2, Wilson Wong1,3. 1. MRC Centre for Transplantation, King's College London, Guy's Hospital, United Kingdom (L.A.E., A.K.N., N.V.J., L.L.M., K.B., A.S., C.L., A.M., W.W.) wilson.wong@kcl.ac.uk lindsey.edwards@kcl.ac.uk. 2. MRC Centre for Transplantation, King's College London, Guy's Hospital, United Kingdom (L.A.E., A.K.N., N.V.J., L.L.M., K.B., A.S., C.L., A.M., W.W.). 3. King's College London, School of Medicine at Guy's, King's and St. Thomas' Hospitals, United Kingdom (W.W.).
Abstract
BACKGROUND: Cardiac transplantation is an excellent treatment for end-stage heart disease. However, rejection of the donor graft, in particular, by chronic rejection leading to cardiac allograft vasculopathy, remains a major cause of graft loss. The lymphatic system plays a crucial role in the alloimmune response, facilitating trafficking of antigen-presenting cells to draining lymph nodes. The encounter of antigen-presenting cells with T lymphocytes in secondary lymphoid organs is essential for the initiation of alloimmunity. Donor lymphatic vessels are not anastomosed to that of the recipient during transplantation. The pathophysiology of lymphatic disruption is unknown, and whether this disruption enhances or hinders the alloimmune responses is unclear. Although histological analysis of lymphatic vessels in donor grafts can yield information on the structure of the lymphatics, the function following cardiac transplantation is poorly understood. METHODS: Using single-photon emission computed tomography/computed tomography lymphoscintigraphy, we quantified the lymphatic flow index following heterotrophic cardiac transplantation in a murine model of chronic rejection. RESULTS: Ten weeks following transplantation of a minor antigen (HY) sex-mismatched heart graft, the lymphatic flow index was significantly increased in comparison with sex-matched controls. Furthermore, the enhanced lymphatic flow index correlated with an increase in donor cells in the mediastinal draining lymph nodes; increased lymphatic vessel area; and graft infiltration of CD4+, CD8+ T cells, and CD68+ macrophages. CONCLUSIONS: Chronic rejection results in increased lymphatic flow from the donor graft to draining lymph nodes, which may be a factor in promoting cellular trafficking, alloimmunity, and cardiac allograft vasculopathy.
BACKGROUND: Cardiac transplantation is an excellent treatment for end-stage heart disease. However, rejection of the donor graft, in particular, by chronic rejection leading to cardiac allograft vasculopathy, remains a major cause of graft loss. The lymphatic system plays a crucial role in the alloimmune response, facilitating trafficking of antigen-presenting cells to draining lymph nodes. The encounter of antigen-presenting cells with T lymphocytes in secondary lymphoid organs is essential for the initiation of alloimmunity. Donor lymphatic vessels are not anastomosed to that of the recipient during transplantation. The pathophysiology of lymphatic disruption is unknown, and whether this disruption enhances or hinders the alloimmune responses is unclear. Although histological analysis of lymphatic vessels in donor grafts can yield information on the structure of the lymphatics, the function following cardiac transplantation is poorly understood. METHODS: Using single-photon emission computed tomography/computed tomography lymphoscintigraphy, we quantified the lymphatic flow index following heterotrophic cardiac transplantation in a murine model of chronic rejection. RESULTS: Ten weeks following transplantation of a minor antigen (HY) sex-mismatched heart graft, the lymphatic flow index was significantly increased in comparison with sex-matched controls. Furthermore, the enhanced lymphatic flow index correlated with an increase in donor cells in the mediastinal draining lymph nodes; increased lymphatic vessel area; and graft infiltration of CD4+, CD8+ T cells, and CD68+ macrophages. CONCLUSIONS: Chronic rejection results in increased lymphatic flow from the donor graft to draining lymph nodes, which may be a factor in promoting cellular trafficking, alloimmunity, and cardiac allograft vasculopathy.
Authors: Hans J Geissler; Alexey Dashkevich; Uwe M Fischer; Jochen W U Fries; Ferdinand Kuhn-Régnier; Klaus Addicks; Uwe Mehlhorn; Wilhelm Bloch Journal: Eur J Cardiothorac Surg Date: 2006-01-24 Impact factor: 4.191
Authors: R Ruggiero; J Muz; R Fietsam; G A Thomas; R J Welsh; J E Miller; L W Stephenson; F A Baciewicz Journal: J Thorac Cardiovasc Surg Date: 1993-07 Impact factor: 5.209
Authors: A C Santos; J J de Lima; M F Botelho; M F Pacheco; P Sousa; J Bernardo; N Ferreira; L Gonçalves; J Aguiar; L A Providência; E K Pauwels Journal: Nucl Med Biol Date: 1998-10 Impact factor: 2.408
Authors: K Brown; A Badar; K Sunassee; M A Fernandes; H Shariff; S Jurcevic; P J Blower; S H Sacks; G E D Mullen; W Wong Journal: Am J Transplant Date: 2011-01-10 Impact factor: 8.086
Authors: Benjamin J Kopecky; Hao Dun; Junedh M Amrute; Chieh-Yu Lin; Andrea L Bredemeyer; Yuriko Terada; Peter O Bayguinov; Andrew L Koenig; Christian C Frye; James A J Fitzpatrick; Daniel Kreisel; Kory J Lavine Journal: Circulation Date: 2022-07-26 Impact factor: 39.918
Authors: Vera Usuelli; Moufida Ben Nasr; Francesca D'Addio; Kaifeng Liu; Andrea Vergani; Basset El Essawy; Jun Yang; Emma Assi; Mayuko Uehara; Chiara Rossi; Anna Solini; Annalisa Capobianco; Elena Rigamonti; Luciano Potena; Massimo Venturini; Mario Sabatino; Lorena Bottarelli; Enrico Ammirati; Maria Frigerio; Eduardo Castillo-Leon; Anna Maestroni; Cinzia Azzoni; Cristian Loretelli; Andy Joe Seelam; Albert K Tai; Ida Pastore; Gabriella Becchi; Domenico Corradi; Gary A Visner; Gian V Zuccotti; Nelson B Chau; Reza Abdi; Marcus G Pezzolesi; Paolo Fiorina Journal: Am J Transplant Date: 2021-05-03 Impact factor: 9.369